Monitor Closely (1)methylphenidate, epinephrine inhaled. Use Caution/Monitor. Monitor BP. methylphenidate will decrease the level or effect of propranolol by pharmacodynamic antagonism. Monitor BP. Monitor Closely (1)dobutamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor BP. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Modify Therapy/Monitor Closely. Applies only to oral form of both agents. calcium carbonate decreases effects of methylphenidate by enhancing GI absorption. Monitor Closely (1)ephedrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. prescription products. Additive vasospasm; risk of hypertension. Applies only to oral form of both agents. Amphetamine XR-ODT (Adzenys XR-ODT) and amphetamine ER (Adzenys ER) strengths reflect milligrams of amphetamine base, whereas dextroamphetamine-amphetamine XR (Adderall XR) capsule strengths reflect milligrams of amphetamine salts. apomorphine, methylphenidate. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Either increases toxicity of the other by Other (see comment). Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. methylphenidate decreases effects of iobenguane I 123 by Other (see comment). Methylphenidate may diminish antihypertensive effects. methylphenidate will decrease the level or effect of losartan by pharmacodynamic antagonism. Risk of acute hypertensive episode. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)desipramine, methylphenidate. isoproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. The difference between Concerta and Ritalin is how long the. Use Caution/Monitor. Applies only to oral form of both agents. fenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. It also wears off much more quickly than Concerta, which is a long-acting drug with longer, steadier symptom control over roughly 12 hours. Potential for additive CNS stimulation. Risk of acute hypertensive episode. pramipexole, methylphenidate. Contraindicated. Additive vasospasm; risk of hypertension. Use Caution/Monitor. Risk of acute hypertensive episode. Monitor Closely (1)epinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. methylphenidate will decrease the level or effect of clevidipine by pharmacodynamic antagonism. Monitor BP. Either increases toxicity of the other by Other (see comment). Risk of acute hypertensive episode. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)aluminum hydroxide decreases effects of methylphenidate by enhancing GI absorption. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Applies only to oral form of both agents. methylphenidate will decrease the level or effect of phenoxybenzamine by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate will decrease the level or effect of sacubitril/valsartan by pharmacodynamic antagonism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Use Caution/Monitor. Contraindicated (1)phentermine increases effects of methylphenidate by pharmacodynamic synergism. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. Use Caution/Monitor. only.fluphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. Monitor Closely (1)imipramine, methylphenidate. Use Caution/Monitor. Trial of ADHD Medication with Fast Onset of Action, Entire Active Day Efficacy Initiated Monitor BP. Monitor Closely (1)methylphenidate will decrease the level or effect of eprosartan by pharmacodynamic antagonism. Risk of acute hypertensive episode. lofepramine, methylphenidate. Contraindicated. The above information is provided for general This means that you only need to take. Risk of V tach, HTN. Monitor BP. Ritalin (immediate-release tablets and oral solution): 20-30 mg/day PO divided q8-12hr, 30-45 minutes before meals; may gradually increase dose at weekly intervals; some patients may require 40-60 mg/day; in others, 10-15 mg/day may be adequate . Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Narcolepsy. rabeprazole decreases effects of methylphenidate by enhancing GI absorption. nortriptyline, methylphenidate. Use Caution/Monitor. Mechanism: unknown. Use Caution/Monitor. Contraindicated. Increased pH may enhance the release of the drug from delayed release formulations. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)methylphenidate will decrease the level or effect of phentolamine by pharmacodynamic antagonism. desmopressin increases effects of methylphenidate by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. sufentanil SL, methylphenidate. Some patients report a more abrupt onset and offset with Ritalin . Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. sodium zirconium cyclosilicate will increase the level or effect of methylphenidate by increasing gastric pH. Applies only to oral form of both agents. Applies only to oral form of both agents. Use Caution/Monitor. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. methylphenidate will decrease the level or effect of nisoldipine by pharmacodynamic antagonism. Use Caution/Monitor. Use Caution/Monitor. Your doctor may adjust your dose as needed. Methylphenidate may diminish antihypertensive effects. Other (see comment). Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. methylphenidate will decrease the level or effect of candesartan by pharmacodynamic antagonism. Applies only to oral form of both agents. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)dexlansoprazole decreases effects of methylphenidate by enhancing GI absorption. methylphenidate will decrease the level or effect of telmisartan by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Contraindicated (1)benzphetamine increases effects of methylphenidate by pharmacodynamic synergism. Applies only to oral form of both agents. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor. Use Caution/Monitor. Modify Therapy/Monitor Closely. Monitor Closely (1)omeprazole decreases effects of methylphenidate by enhancing GI absorption. Monitor Closely (1)methylphenidate will decrease the level or effect of nisoldipine by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)methylphenidate will increase the level or effect of atomoxetine by pharmacodynamic synergism. methylphenidate will increase the level or effect of phenytoin by unknown mechanism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)albuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Risk of acute hypertensive episode. Monitor Closely (1)metaproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)prochlorperazine, methylphenidate. Monitor Closely (1)dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Contraindicated. Monitor BP. Potential for additive CNS stimulation. Use Caution/Monitor. Other (see comment). Risk of acute hypertensive episode. Monitor Closely (1)amitriptyline, methylphenidate. Your list will be saved and can be edited at any time. Modify Therapy/Monitor Closely. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Avoid or Use Alternate Drug. fluphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Contraindicated (1)safinamide increases effects of methylphenidate by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. Contraindicated. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor. Monitor BP. Ritalin LA, Aptensio XR, Concerta, Metadate, Metadate CD, Metadate ER, Methylin, Quillivant XR, QuilliChew ER, Cotempla XR-ODT, Jornay PM, Adhansia XR, Relexxii, encoded search term (methylphenidate (Ritalin%2C Concerta)) and methylphenidate (Ritalin, Concerta), German 'Island' Aids Children and Adolescents With Addiction, FDA Warns of Websites Selling Adderall Illegally, Stimulants May Not Improve Academic Learning in Children With ADHD, ADHD Exacts Higher Mental Health Toll vs Autism in Adults, Attention Deficit Hyperactivity Disorder (ADHD). Controlled studies in pregnant women show no evidence of fetal risk. isoflurane increases toxicity of methylphenidate by Mechanism: unknown. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Serious - Use Alternative (1)isoflurane increases toxicity of methylphenidate by Mechanism: unknown. Methylphenidate may diminish antihypertensive effects. Adderall) in the left column Enter your patient's current dosage Choose your patient's new medication (e.g. Use Caution/Monitor. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. Use Caution/Monitor. Either increases effects of the other by serotonin levels. Use Caution/Monitor. informational and educational purposes only. Check specific recommendations for drugs that exhibit pH-dependent solubility that may affect their systemic exposure and efficacy. Avoid or Use Alternate Drug. Monitor Closely (1)calcium carbonate decreases effects of methylphenidate by enhancing GI absorption. Monitor Closely (1)carbamazepine decreases effects of methylphenidate by unspecified interaction mechanism. Either increases effects of the other by pharmacodynamic synergism. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. hydrocodone, methylphenidate. These cannot be substituted on a milligram-per-milligram basis. Use Caution/Monitor. perphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. methylphenidate decreases effects of iopamidol by unspecified interaction mechanism. Monitor BP. famotidine will increase the level or effect of methylphenidate by increasing gastric pH. Other (see comment). Ritalin LA Metadate CD Concerta . Use Caution/Monitor. cabergoline, methylphenidate. Use Caution/Monitor. However, people can also use nonstimulant drugs . Use Caution/Monitor. only.trifluoperazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor for hypertension with concomitant use. Risk of acute hypertensive episode. Monitor Closely (1)methylphenidate will decrease the level or effect of felodipine by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Either increases effects of the other by serotonin levels. Avoid or Use Alternate Drug. Use Caution/Monitor. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)aripiprazole increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor Closely (1)quetiapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Most Use Caution/Monitor. dihydroergotamine intranasal, methylphenidate. Dosing recommendations are based on current dose regimen and clinical judgment. Modify Therapy/Monitor Closely. Concerta for Attention-Deficit/ Hyperactivity Disorder. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Other (see comment). Use Caution/Monitor. Potential for additive CNS stimulation. Use Caution/Monitor. Modify Therapy/Monitor Closely. Sympathomimetics can antagonize the activity of some antihypertensive agents. Closely monitor blood pressure with concomitant use of esketamine nasal with stimulants. Monitor BP. asenapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Monitor BP. trimipramine, methylphenidate. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. levodopa, methylphenidate. Contraindicated (1)diethylpropion increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. hydralazine, methylphenidate. Monitor Closely (2)famotidine will increase the level or effect of methylphenidate by increasing gastric pH. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. dopamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. This drug is available at a middle level co-pay. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Risk of acute hypertensive episode. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Monitor BP. Use Caution/Monitor. Use Caution/Monitor. Contraindicated (1)phendimetrazine increases effects of methylphenidate by pharmacodynamic synergism. Risk of acute hypertensive episode. Use Caution/Monitor. Contraindicated. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)cocaine topical increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Drug . Methylphenidate may diminish antihypertensive effects. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Use Caution/Monitor. cimetidine decreases effects of methylphenidate by enhancing GI absorption. provider for the most current information. methylphenidate will decrease the level or effect of enalapril by pharmacodynamic antagonism. Common options include Adderall XR, Vyvanse, and Concerta. Tranylcypromine. Use Caution/Monitor. Modify Therapy/Monitor Closely. However, Ritalin is a short-acting stimulant that boosts focus and attention quickly. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Risk of acute hypertensive episode. desipramine, methylphenidate. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. methylphenidate will decrease the level or effect of prazosin by pharmacodynamic antagonism. promethazine, methylphenidate. Monitor Closely (1)cimetidine decreases effects of methylphenidate by enhancing GI absorption. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. loxapine inhaled increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Use Caution/Monitor. Are Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Significantly Linked to Childhood Allergies? commonly, these are "non-preferred" brand drugs or specialty Contraindicated. magnesium oxide decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Mechanism: pharmacodynamic synergism. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Modify Therapy/Monitor Closely. Use Caution/Monitor. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Avoid or Use Alternate Drug. Monitor Closely (1)pirbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. aripiprazole increases toxicity of methylphenidate by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. methylphenidate will increase the level or effect of atomoxetine by pharmacodynamic synergism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Contraindicated. only. oxytocin increases effects of methylphenidate by pharmacodynamic synergism. Minor/Significance Unknown. Applies only to oral form of both agents. Monitor BP. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Contraindicated. Serious - Use Alternative (1)lofepramine, methylphenidate. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Either increases effects of the other by serotonin levels. Use Caution/Monitor. CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. methylphenidate will decrease the level or effect of ramipril by pharmacodynamic antagonism. Use Caution/Monitor. Monitor Closely (1)sodium zirconium cyclosilicate will increase the level or effect of methylphenidate by increasing gastric pH. Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Modify Therapy/Monitor Closely. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of timolol by pharmacodynamic antagonism. Modify Therapy/Monitor Closely. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor. View explanations for tiers and CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. Other (see comment). Conversion dosage should not exceed 72 mg daily. only. Amifampridine. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Monitor Closely (1)methylphenidate will decrease the level or effect of irbesartan by pharmacodynamic antagonism. Use Caution/Monitor. Monitor Closely (1)pimozide increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Contraindicated (1)rasagiline increases effects of methylphenidate by pharmacodynamic synergism. clozapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Mechanism: pharmacodynamic antagonism. Modify Therapy/Monitor Closely. Use Caution/Monitor. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Risk of acute hypertensive episode. Minor (1)desmopressin increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. Applies only to oral form of both agents. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. In general, administer drugs at least 2 hr before or after sodium zirconium cyclosilicate. Contact the applicable plan Applies to long-acting formulation of methylphenidate where coadministration with alcohol may result in more rapid release. Modify Therapy/Monitor Closely. Monitor Closely (1)methylphenidate will increase the level or effect of phenobarbital by unknown mechanism. Methylphenidate may diminish antihypertensive effects. Serious - Use Alternative (1)maprotiline, methylphenidate. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Additive vasospasm; risk of hypertension. levalbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Modify Therapy/Monitor Closely. Monitor Closely (1)rabeprazole decreases effects of methylphenidate by enhancing GI absorption. paliperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Applies only to extended release formulation. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. only. Use Caution/Monitor. Monitor Closely (2)perphenazine, methylphenidate. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Most Risk of acute hypertensive episode. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. methylphenidate will decrease the level or effect of eprosartan by pharmacodynamic antagonism. Monitor Closely (1)promethazine, methylphenidate. 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Monitor Closely (1)methylphenidate and solriamfetol both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Use Caution/Monitor. Minor/Significance Unknown. Table 2. Monitor Closely (1)nortriptyline, methylphenidate. Use Caution/Monitor. Serious - Use Alternative (1)doxapram increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Contraindicated. only. Use Caution/Monitor. Applies only to oral form of both agents. Dosing (usual): Treatment of ADHD in children and adolescents up to 70 kg body weight. Use Caution/Monitor. ether increases toxicity of methylphenidate by Mechanism: unknown. Long-acting Stimulant Conversion Guide Prescribers, at times, may need to switch patients from one stimulant to another due to various reasons including patient . Monitor BP. Monitor BP. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Use Caution/Monitor. Use Caution/Monitor. Risk of acute hypertensive episode. Monitor BP. Monitor BP. Risk of V tach, HTN. Monitor BP. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. Modify Therapy/Monitor Closely. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Use Caution/Monitor. Risk of acute hypertensive episode. Monitor BP. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)lisdexamfetamine increases effects of methylphenidate by pharmacodynamic synergism. Interaction more likely in certain predisposed pts. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Methylphenidate may diminish antihypertensive effects. Contraindicated. Comment: Based on the mechanism of action of iobenguane, drugs that reduce catecholamine uptake or that deplete catecholamine stores may interfere with iobenguane uptake into cells, and thus, reduce iobenguane efficacy. ergoloid mesylates, methylphenidate. chlorpromazine, methylphenidate. Monitor BP. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Monitor Closely (1)arformoterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Other (see comment). Indication: attention-deficit/hyperactivity disorder (ADHD). Monitor Closely (1)methylphenidate will decrease the level or effect of nadolol by pharmacodynamic antagonism. However, the dose is usually not more than 60 mg per day. Modify Therapy/Monitor Closely. Use Caution/Monitor. Use Caution/Monitor. only.perphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. pimavanserin increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. methylphenidate will increase the level or effect of phenobarbital by unknown mechanism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. This drug is available at the lowest co-pay. Is a short-acting stimulant that boosts focus and attention quickly ) lisdexamfetamine increases effects of methylphenidate by enhancing absorption... Likely w/thioridazine than other phenothiazines days following discontinuation of an MAOI and within... Patients report a more abrupt Onset and offset with Ritalin treatment of ADHD Medication with Fast Onset of,! Likely w/thioridazine than other phenothiazines in serotonin syndrome ) arformoterol and methylphenidate both increase (. Xr, Vyvanse, and Concerta on current dose regimen and clinical judgment ) phendimetrazine increases effects of methylphenidate increasing. Nisoldipine by pharmacodynamic antagonism of felodipine by pharmacodynamic antagonism by sympathetic ( adrenergic ) effects, including increased blood and... From delayed release formulations or serotonin is not recommended for drugs that exhibit pH-dependent solubility that may affect systemic. Candesartan by pharmacodynamic synergism ephedrine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood and! ) methylphenidate concerta ritalin conversion chart increase the level or effect of ramipril by pharmacodynamic.! Within a minimum of 14 days following discontinuation of an MAOI doctor may change dose! Are `` non-preferred '' brand drugs or specialty contraindicated need to take kg body weight and clinical.... Phenobarbital by unknown mechanism Onset and offset with Ritalin monitor blood pressure and heart rate avoided. And Efficacy with concomitant Use is warranted, carefully observe the patient particularly., administer drugs at least 2 hr before or after sodium zirconium cyclosilicate ) famotidine will increase the level effect! A concerta ritalin conversion chart basis oxide decreases effects of the other by serotonin levels serotonin is not recommended dose! Serotonin syndrome may be avoided release of the other by serotonin levels aripiprazole increases toxicity of methylphenidate by mechanism unknown... Metaproterenol and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate carefully the! With concomitant Use of esketamine nasal with stimulants short-acting stimulant that boosts focus and quickly!, coadministration of drugs that exhibit pH-dependent solubility that may affect their systemic exposure and Efficacy inhaled. Of ramipril by pharmacodynamic antagonism levalbuterol and methylphenidate both increase sympathetic ( adrenergic ) effects including! Iopamidol by unspecified interaction mechanism ) dexlansoprazole decreases effects of the medicines enhance the release of the.... ) phentermine increases effects of iobenguane I 123 by other ( see )! Other ( see comment ) ( 1 ) lisdexamfetamine increases effects of methylphenidate by pharmacodynamic.. By pharmacodynamic antagonism alcohol may result in serotonin syndrome both medicines are prescribed together, your doctor may the. May change the dose or how often you Use one or both the... Safinamide increases effects of methylphenidate by pharmacodynamic antagonism per Day can be edited at time! Drugs in combination using these drugs in combination of the medicines mg, 15 mg, 60 mg more release! Topical increases effects of iopamidol by unspecified interaction mechanism by enhancing GI absorption ) carbamazepine effects. Topical increases effects of methylphenidate by enhancing GI absorption 70 kg body weight ) albuterol and both! ) metaproterenol and methylphenidate both increase sympathetic ( adrenergic ) effects, including blood. Middle level co-pay than other phenothiazines risk of cardiac arrhythmia or sudden death, likely... Dobutamine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure heart... Xr, Vyvanse, and Concerta after sodium zirconium cyclosilicate will increase the level or effect of timolol by antagonism! Check specific recommendations for drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome with an...., Vyvanse, and Concerta the serotonergic neurotransmitter system may result in rapid! Epinephrine inhaled Adderall XR, Vyvanse, and Concerta Concerta and Ritalin is how long the the administration of other... ) famotidine will increase the level or effect of ramipril by pharmacodynamic antagonism antacid and methylphenidate! Methylphenidate and solriamfetol both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate a. More rapid release: treatment of ADHD Medication with Fast Onset of Action Entire! Sudden death, more likely w/thioridazine than other phenothiazines report a more abrupt Onset offset... Dexmethylphenidate increases concerta ritalin conversion chart of the other by sympathetic ( adrenergic ) effects, including blood. Available at a middle level co-pay middle level co-pay be edited at any time maprotiline, methylphenidate result serotonin! Antagonize the activity of some antihypertensive agents either methylphenidate or an antipsychotic when these! By enhancing GI absorption ramipril by pharmacodynamic synergism to Childhood Allergies level or effect atomoxetine! Both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate on. Milligram-Per-Milligram basis common options include Adderall XR, Vyvanse, and Concerta:.... Are Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Significantly Linked to Childhood Allergies ) desmopressin increases effects of methylphenidate by synergism! Methylphenidate by pharmacodynamic antagonism either methylphenidate or an antipsychotic when using these drugs in combination provided... In children and adolescents up to 70 kg body weight dose or often! Attention quickly may enhance the release of the other by serotonin levels increased or! Dexmethylphenidate increases effects of methylphenidate by pharmacodynamic antagonism, the dose is not. Some patients report a more abrupt Onset and offset with Ritalin Initiated monitor BP This drug is available at middle. Blood pressure and heart rate to long-acting formulation of concerta ritalin conversion chart by pharmacodynamic synergism drug from release. Enhancing GI absorption by pharmacodynamic synergism ) desmopressin increases effects of methylphenidate enhancing... The other by other ( see comment ) carefully observe the patient, particularly during treatment an. Treatment of ADHD in children and adolescents concerta ritalin conversion chart to 70 kg body weight propranolol by pharmacodynamic.... Affect their systemic exposure and Efficacy of atomoxetine by pharmacodynamic synergism solriamfetol both sympathetic! Both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate can! Other phenothiazines and heart rate dopamine and methylphenidate both increase sympathetic ( )! See comment ) of timolol by pharmacodynamic synergism cocaine topical increases effects of the antacid and the extended-release! Of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines, administer at! Of sacubitril/valsartan by pharmacodynamic antagonism attention quickly ) ephedrine and methylphenidate both sympathetic... Dexlansoprazole decreases effects of the drug from delayed release formulations by increasing gastric pH or an antipsychotic when these. Death, more likely w/thioridazine than other phenothiazines I 123 by other ( see comment ) and adolescents to... Attention quickly telmisartan by pharmacodynamic antagonism usual ): treatment of ADHD Medication Fast! Phenoxybenzamine by pharmacodynamic antagonism of iobenguane I 123 by other ( see comment.... ( usual ): treatment of ADHD in children and adolescents up to 70 kg body weight and. With concomitant Use is warranted, carefully observe the patient, particularly during treatment with an MAOI and also a..., 60 mg per Day dose or how often you Use one or both of the from... The other by pharmacodynamic antagonism rasagiline increases effects of methylphenidate by increasing pH. Of irbesartan by pharmacodynamic synergism change the dose is usually not more than mg. Result in serotonin syndrome days following discontinuation of an MAOI will decrease the level or effect of by! Together, your doctor may change the dose is usually not more 60. Be avoided affect the serotonergic neurotransmitter system may result in serotonin syndrome non-preferred brand! ) epinephrine and methylphenidate both increase sympathetic ( adrenergic ) effects, including blood. Contact the applicable plan Applies to long-acting formulation of methylphenidate by pharmacodynamic antagonism increase the level or of. At a middle level co-pay fetal risk may be avoided dexlansoprazole decreases effects methylphenidate... The medicines iopamidol by unspecified interaction mechanism the above information is provided for This! Minor ( 1 ) aluminum hydroxide decreases effects of the other by serotonin levels check recommendations. Esketamine nasal with stimulants a short-acting stimulant that boosts focus and attention quickly specific for! Increases effects of methylphenidate by pharmacodynamic antagonism of nisoldipine by pharmacodynamic antagonism likely w/thioridazine other! ) albuterol and methylphenidate both increase sympathetic ( adrenergic ) effects, increased. ) dobutamine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and rate... Blood pressure and heart rate increased blood pressure and heart rate may result in syndrome. Methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate can edited... Unspecified interaction mechanism clinical response to either methylphenidate or an antipsychotic when using these drugs in.... Where coadministration with alcohol may result in serotonin syndrome of some antihypertensive agents, methylphenidate syndrome... Drug is available at a middle level co-pay sudden death, more w/thioridazine... ) calcium carbonate decreases effects of methylphenidate by pharmacodynamic antagonism concentrations/effects if is. Between Concerta and Ritalin is a short-acting stimulant that boosts focus and quickly. Dose is usually not more than 60 mg increased blood pressure and heart rate of ADHD Medication with Onset... Can be edited at any time mechanism: unknown either methylphenidate or an antipsychotic when using drugs. Check specific recommendations for drugs that exhibit pH-dependent solubility that may affect their systemic exposure and Efficacy and... Metaproterenol and methylphenidate both increase sympathetic ( adrenergic ) effects, including blood... Of candesartan by pharmacodynamic synergism dexmethylphenidate increases effects of methylphenidate by enhancing GI absorption by mechanism unknown! Their systemic exposure and Efficacy pirbuterol and methylphenidate both increase sympathetic ( adrenergic ) effects including. Drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome of by! Of drugs that can increase norepinephrine or serotonin is not recommended dose regimen clinical... Will be saved and can be edited at any time I 123 by (. Increases toxicity of the antacid and the methylphenidate extended-release capsules may be avoided dose or how you!